Aurélien Bernard is the Chief Scientific Officer and Co-Founder of KERANOVA S.A., a position held since 2016, where they manage, develop, and test research projects while overseeing product risk management. Previously, they contributed to the development of bioactive glass bone substitutes at NORAKER and managed clinical study projects during their postdoctoral research at Laboratoire BiiGC. Aurélien holds a Doctorate in Clinical Trials and Technological Innovations from Université Jean Monnet Saint-Etienne, as well as multiple degrees in biomedical engineering and cellular and tissue engineering.
Location
Lyon, France
Links
This person is not in any teams
This person is not in any offices